Physician profile
Dongsoo Kim
NPI 1821016957
$17,470.89
in general payments reported to CMS, 2019-2025
14 companies · $4,443 in 2025
The $4,443 reported for 2025 was more than what 96% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,394 · 2020: $2,726 · 2021: $635 · 2022: $3,716 · 2023: $2,249 · 2024: $1,308 · 2025: $4,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,751 · Consulting Fee: $1,500 · Travel and Lodging: $1,499 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,750.84 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,499.01 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $8,068.93 | 2020-2025 | |
| Kls-Martin L.P. | $4,900.07 | 2019-2025 | |
| Depuy Synthes Sales INC. | $1,570.33 | 2020-2025 | Trumatch, Na |
| Axogen | $1,082.40 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Smith+Nephew, INC. | $545.79 | 2019-2025 | Stravix Pl, Stravix, Grafix |
| Stryker Corporation | $362.41 | 2019-2024 | Na |
| Mimedx Group, INC. | $203.75 | 2025 | |
| Kerecis Limited | $174.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Straumann USA LLC | $142.67 | 2023 | |
| Solventum Corporation | $112.68 | 2024-2025 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice, Prevena |
| Sanara Medtech INC. | $106.79 | 2022 | |
| Integra Lifesciences Corporation | $94.57 | 2020 | |
| Biocomposites INC | $86.15 | 2025 | Stimulan |
| Vioptix INC | $19.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dongsoo Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.